Article Information
History
- November 12, 2020.
Article Versions
- You are currently viewing Version 1 of this article (November 12, 2020 - 14:43).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Simon Mauras1,
- Vincent Cohen-Addad,
- Guillaume Duboc,
- Max Dupré la Tour,
- Paolo Frasca2,
- Claire Mathieu3,*,
- Lulla Opatowski and
- Laurent Viennot4
- 1IRIF, Paris. V. Cohen-Addad is with Google Research, Brand-schenkestrasse 110, 8002 Zürich, Switzerland
- 2Univ. Grenoble Alpes, CNRS, Inria, Grenoble INP, Gipsa-lab, F-38000 Grenoble, France
- 3CNRS, IRIF, Paris. L. opatowski is with Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France, and with Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion unit, Paris, France
- 4INRIA, IRIF, Paris
- ↵*Corresponding author; email: clairemmathieu{at}gmail.com